2025-01-18 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Review

**1. Performance Comparison and Divergence:**

Teladoc Health (TDOC) has significantly underperformed the S&P 500 (VOO) over the observed period.  The cumulative return for TDOC is -67.86%, while VOO's is 118.33%. This represents a massive divergence of **186.19%**.  The provided relative divergence of 0.3 indicates that TDOC's performance is relatively close to its historical minimum performance compared to the S&P 500.  The company provides telehealth services.


**2. Recent Price Movement:**

* **Closing Price:** $9.09
* **5-Day Moving Average:** $9.33
* **20-Day Moving Average:** $9.45
* **60-Day Moving Average:** $9.76

The price is currently trading below all three moving averages, suggesting a bearish short-term trend.

**3. Technical Indicators and Expected Return:**

* **RSI (40.91):**  Approaching oversold territory (below 30), suggesting potential for a bounce, but not confirming a bullish reversal.
* **PPO (-0.40):** Negative PPO indicates bearish momentum.
* **Relative Divergence:** A -0.9 change in relative divergence over 20 days indicates a short-term downward trend.
* **Expected Return (-6813.2%):** This extremely negative expected return highlights the significant risk associated with TDOC. The model's prediction of a substantial negative return suggests a very high degree of pessimism regarding future performance.  This should be viewed with caution, as such extreme predictions often have large error bars.  Long-term investment requires careful consideration of this high risk.  Long-term gains are not assured, and may well remain well below the S&P 500.

**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue      |
|------------|--------|--------------|
| 2024-10-31 | -$0.19 | $0.64B       |
| 2024-08-01 | -$4.92 | $0.64B       |
| 2024-04-26 | -$0.49 | $0.65B       |
| 2023-10-27 | -$0.35 | $0.66B       |
| 2023-10-31 | -$0.35 | $0.66B       |


Earnings have been consistently negative in recent quarters. While revenue remains relatively stable, the significant negative EPS is a major concern.  The August 2024 earnings report stands out dramatically, indicating a potentially one-time unusual event. Further investigation is required to ascertain the cause of this unusually large negative EPS.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue      | Profit Margin |
|------------|--------------|---------------|
| 2024-09-30 | $0.64B       | 71.94%        |
| 2024-06-30 | $0.64B       | 70.73%        |
| 2024-03-31 | $0.65B       | 69.89%        |
| 2023-12-31 | $0.66B       | 70.72%        |
| 2023-09-30 | $0.66B       | 71.83%        |

**Capital and Profitability:**

| Quarter    | Equity       | ROE          |
|------------|--------------|--------------|
| 2024-09-30 | $1.51B       | -2.21%       |
| 2024-06-30 | $1.50B       | -55.77%      |
| 2024-03-31 | $2.29B       | -3.58%       |
| 2023-12-31 | $2.33B       | -1.24%       |
| 2023-09-30 | $2.29B       | -2.49%       |

Revenue has remained relatively stable.  However, the consistently negative ROE is a significant red flag, indicating that the company is not generating sufficient returns on its equity. The extremely negative ROE in Q2 2024 warrants further investigation.


**7. Overall Analysis:**

TDOC is currently experiencing significant challenges.  Negative earnings, a negative ROE, and substantial underperformance against the S&P 500 paint a bearish picture. While the RSI suggests potential oversold conditions, the other indicators and the company's fundamentals point to continued downside risk.  The exceptionally negative projected return should be treated with caution but highlights the significant risk involved.  A long-term investment strategy would require a very high risk tolerance and a belief in the company's ability to reverse its current negative trends.  The August 2024 EPS result necessitates detailed analysis to understand the contributing factors. Before making any investment decision,  thorough due diligence, including analysis of the August 2024 earnings report and future earnings projections, is crucial.

**8. Disclaimer:** This analysis is for informational purposes only and does not constitute financial advice.  The extremely negative projected returns are model predictions and should not be taken as definitive future outcomes.  Investment decisions should be based on your own due diligence and risk tolerance.
